HCMV IE2-mediated inhibition of HAT activity downregulates p53 function

EMBO Journal

Volumn 23, Issue 11, 2004, Pages 2269-2280

  Hsu, Chih Hung ^a,b   Chang, Margaret D T ^a   Tai, Kang Yu ^b   Yang, Yu Ting ^b   Wang, Pei Shan ^b   Chen, Chi Ju ^c   Wang, Yan Hsiung ^d   Lee, Sheng Chung ^d   Wu, Cheng Wen ^b,e   Juan, Li Jung ^b  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

HAT; HCMV; IE2; p53

Indexed keywords

ACYLTRANSFERASE; AMINO ACID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HISTONE; HISTONE ACETYLTRANSFERASE; IMMEDIATE EARLY 2 PROTEIN; IMMEDIATE EARLY PROTEIN; PROTEIN P300; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACETYLATION; AMINO TERMINAL SEQUENCE; ANTIAPOPTOTIC EFFECT; APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IN VIVO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN TARGETING; TRANSACTIVATION;

ACETYLTRANSFERASES; AMINO ACID SEQUENCE; ANNEXIN A5; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYTOMEGALOVIRUS; HISTONE ACETYLTRANSFERASES; HUMANS; IMMEDIATE-EARLY PROTEINS; LUNG NEOPLASMS; MUTAGENESIS, SITE-DIRECTED; MUTATION; NUCLEAR PROTEINS; PLASMIDS; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 3042600724     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600239     Document Type: Article

References (45)

1. Asahara H, Tartare-Deckert S, Nakagawa T, Ikehara T, Hirose F, Hunter T, Ito T, Montminy M (2002) Dual roles of p300 in chromatin assembly and transcriptional activation in cooperation with nucleosome assembly protein 1 in vitro. Mol Cell Biol 22: 2974-2983
2. Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K (1997) Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89: 1175-1184
3. Bannister AJ, Kouzarides T (1996) The CBP co-activator is a histone acetyltransferase. Nature 384: 641-643
4. Brooks CL, Gu W (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164-171
5. Brown CE, Lechner T, Howe L, Workman JL (2000) The many HATs of transcription coactivators. Trends Biochem Sci 25: 15-19
6. Bryant LA, Mixon P, Davidson M, Bannister AJ, Kouzarides T, Sinclair JH (2000) The human cytomegalovirus 86-kilodalton major immediate-early protein interacts physically and functionally with histone acetyltransferase P/CAF. J Virol 74: 7230-7237
7. Caron C, Col E, Khochbin S (2003) The viral control of cellular acetylation signaling. BioEssays 25: 58-65
8. Castillo JP, Kowalik TF (2002) Human cytomegalovirus immediate early proteins and cell growth control. Gene 290: 19-34
9. Castillo JP, Yurochko AD, Kowalik TF (2000) Role of human cytomegalovirus immediate-early proteins in cell growth control. J Virol 74: 8028-8037
10. Chakravarti D, Ogryzko V, Kao HY, Nash A, Chen H, Nakatani Y, Evans RM (1999) A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96: 393-403
11. Chen CJ, Deng Z, Kim AY, Blobel GA, Lieberman PM (2001) Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators. Mol Cell Biol 21: 476-487
12. Chen JY, Funk WD, Wright WE, Shay JW, Minna JD (1993) Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences. Oncogene 8: 2159-2166
13. el-Deiry WS (1998) Regulation of p53 downstream genes. Semin Cancer Biol 8: 345-357
14. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825
15. Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y, Livingston DM (2003) Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300: 342-344
16. Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606
17. Gu W, Shi X-L, Roeder RG (1997) Synergistic activation of transcription by CBP and p53. Nature 387: 819-827
18. Hermiston TW, Malone CL, Witte PR, Stinski MF (1987) Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter. J Virol 61: 3214-3221
19. Ishizuka T, Lazar MA (2003) The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol Cell Biol 23: 5122-5131
20. Ito A, Lai CH, Zhao X, Saito S, Hamilton MH, Appella E, Yao TP (2001) p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 20: 1331-1340
21. Jin Y, Zeng SX, Dai MS, Yang XJ, Lu H (2002) MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation. J Biol Chem 277: 30838-30843
22. Juan LJ, Shia WJ, Chen MH, Yang WM, Seto E, Lin YS, Wu CW (2000) Histone deacetylases specifically down-regulate p53-dependent gene activation. J Biol Chem 275: 20436-20443
23. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, Pelicci PG, Kouzarides T (2002) Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 21: 2383-2396
24. Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD, Berger SL (1999) p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 19: 1202-1209
25. Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W (2004) Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci USA 101: 2259-2264
26. Luo J, Su F, Chen D, Shiloh A, Gu W (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408: 377-381
27. Mauser A, Saito S, Appella E, Anderson CW, Seaman WT, Kenney S (2002) The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J Virol 76: 12503-12512
28. Nakamura S, Roth JA, Mukhopadhyay T (2000) Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. Mol Cell Biol 20: 9391-9398
29. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959
30. Prives C, Manley JL (2001) Why is p53 acetylated? Cell 107: 815-818
31. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW, Appella E (1998) DNA damage activates p53 through a phosphorylation- acetylation cascade. Genes Dev 12: 2831-2841
32. Sax JK, Fei P, Murphy ME, Bernhard E, Korsmeyer SJ, El-Deiry WS (2002) BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol 4: 842-849
33. Schwartz R, Helmich B, Spector DH (1996) CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter. J Virol 70: 6955-6966
34. Shieh S-Y, Ikeda M, Taya Y, Prives C (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334
35. Skaletskaya A, Bartle LM, Chittenden T, McCormick AL, Mocarski ES, Goldmacher VS (2001) A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci USA 98: 7829-7834
36. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265: 391-394
37. Szak ST, Mays D, Pietenpol JA (2001) Kinetics of p53 binding to promoter sites in vivo. Mol Cell Biol 21: 3375-3386
38. Tsai HL, Kou GH, Chen SC, Wu CW, Lin YS (1996) Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53. J Biol Chem 271: 3534-3540
39. Tsai HL, Kou GH, Tang F-M, Wu CW, Lin YS (1997) Negative regulation of a heterologous promoter by human cytomegalovirus immediate-early protein IE2. Virology 238: 372-379
40. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159
41. Wahl GM, Carr AM (2001) The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat Cell Biol 3: E277-E286
42. Wang YC, Huang CF, Tung SF, Lin YS (2000) Competition with TATA box-binding protein for binding to the TATA box implicated in human cytomegalovirus IE2-mediated transcriptional repression of cellular promoters. DNA Cell Biol 19: 613-619
43. Wang YF, Chen SC, Wu FY, Wu CW (1997) The interaction between human cytomegalovirus immediate-early gene 2 (IE2) protein and heterogeneous ribonucleoprotein Al. Biochem Biophys Res Commun 232: 590-594
44. Wang YH, Tsay YG, Tan BC, Lo WY, Lee SC (2003) Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305. J Biol Chem 278: 25568-25576
45. Zhang W, Guo XY, Hu GY, Liu WB, Shay JW, Deisseroth AB (1994) A temperature-sensitive mutant of human p53. EMBO J 13: 2535-2544